What Is Eso Friendly? An Evidence-Based Guide to Chemical Safety

What you find, when you start looking, is a gap between what the label tells you and what the research says — and the gap is wider than it should be. One of those ingredients, a parabenA preservative used in cosmetics and personal care products. Parabens bind weakly to estrogen receptors, which is why they're classified as endocrine disruptors., binds to the same receptor your estrogen uses. Another, a phthalateA class of chemicals used to make plastics flexible and to carry fragrance compounds. Several phthalates are classified as reproductive toxicants — they interfere with androgen signaling during fetal development. hiding behind the single word 'fragrance,' is classified as a reproductive toxicant. A third won't clear your body for years. Each was tested alone, at high doses, in adult rats. Declared safe. What all twelve do together, absorbed through your skin for twelve hours a day, has barely been studied.

In 2024, Braun et al. 2024 drew blood from 624 pregnant women in the German LiNA cohort, identified 294 different chemicals, and then took the combined extract — the actual, real-world chemical soup those women were carrying — and poured it onto developing nerve cells in a dish. The mixture was neurotoxic at concentrations where every individual chemical, tested alone, looked harmless. It confirmed what Silva et al. 2002, working out of the University of London, first demonstrated twenty-two years earlier: eight estrogenic chemicals, each below its individual no-effect threshold, combined into a mixture that produced a significant estrogenic response anyway. They titled the paper Something From Nothing. Eight nothings added up to something.

So the useful question isn't 'is this ingredient safe?' It's 'given what the research actually says about the chemicals in this bottle and the ones it'll be sitting alongside on my skin — should I pick a different one?' A filter, not a label. The rest of this article is what the filter is made of.

Eso friendly is a decision filter that checks whether a product's ingredients carry a plausible mechanism for harming your endocrine systemThe network of glands and organs that produce hormones — the chemical messengers that regulate growth, metabolism, reproduction, mood, and immunity. Operates at parts-per-trillion concentrations., backed by peer-reviewed evidence. The name comes from the Greek for 'within' — the opposite of eco, which comes from the Greek for 'outside.' Environment, ecosystem, ecology — all outward-facing words. Eso comes from the Greek for 'within.' The distinction matters because the two sometimes point in opposite directions. Paper straws are eco-friendly. They're also full of forever chemicals. More on that in a second.

'Is it eso friendly?' works the way 'is it vegan?' works. You're not conducting a clinical trial. You're applying a filter. The filter checks two things: is there a biological reason this chemical could cause harm — does it bind to hormone receptors, accumulate in tissue instead of clearing, cross the placenta? And do peer-reviewed studies find effects consistent with that mechanism? If the biology says harm is plausible and the research says it's consistent, that's enough to choose something else. You're picking a different shampoo, not writing a thesis.

What the filter is not is more important than what it is, because the marketing language it replaces is designed to sound like it already answers this question.

'Natural' has no legal definition for cosmetics. A fully synthetic product with no evidence of endocrine disruption is a better choice than an 'all-natural' one containing a known carcinogen — brown rice has 1.7 times more inorganic arsenic than white (FDAUS Food and Drug Administration — the federal agency responsible for food, drug, and cosmetic safety. risk assessment), and arsenic is a Group 1 carcinogen. 'Clean' has no scientific definition either; Sephora's 'Clean at Sephora' uses different criteria from Target's 'Target Clean,' and the word means whatever the retailer decides it means. 'Eco-friendly' addresses environmental impact, which is a different question entirely. Boisacq et al. 2023 tested 39 drinking straw brands across five materials and found PFASPer- and polyfluoroalkyl substances — a class of 'forever chemicals' used for stain, water, and grease resistance. Persist in the environment and in human blood for years. in nearly every paper and bamboo straw they tested — stainless steel was the only material consistently PFAS-free. The coating that makes plant fibre resist liquid is exactly the class of forever chemicals the environmental swap was supposed to avoid. B Corp certification audits social and environmental practices; it doesn't touch ingredient safety. The EU Ecolabel does ban substances of very high concern, but it's the exception.

And 'free-from' is the most misleading of all. It tells you what was removed. It says nothing about what replaced it.

Here's the part that surprises most people. In the US, cosmetics require zero FDA pre-market approval. Not limited approval. Not streamlined approval. Zero. A company can formulate a product, package it, and sell it without submitting a single safety test to any government body. The only exception is color additives. Everything else — surfactants, preservatives, fragrance chemicals, plasticizers — goes to market on the manufacturer's own assessment of safety, which they are not required to share.

The EU's REACHRegistration, Evaluation, Authorisation and Restriction of Chemicals — the EU's chemical safety regulation, in force since 2007. regulation is more rigorous — it requires hazard data scaled by production tonnage — but it doesn't individually evaluate every ingredient in every consumer product. The UK mirrors the EU framework post-Brexit. Compare that to pharmaceuticals: 10-15 years of preclinical and clinical trials, three phases of human testing, and independent review before a single pill reaches a pharmacy shelf. The active ingredient in an over-the-counter headache tablet was studied more rigorously than every chemical in your bathroom combined.

The EU has registered about 23,000 chemical substances under REACH — a small fraction have been tested for endocrine-disrupting activity. The EPAUS Environmental Protection Agency — the federal agency responsible for environmental and chemical regulation.'s TSCAToxic Substances Control Act — the main US chemical regulation law, originally passed in 1976. Governs the EPA's chemical inventory. inventory lists 86,000+ chemical substances — most never tested for endocrine-disrupting activity — a hundred and nine thousand chemicals, most untested for this. Most have never been tested for endocrine-disrupting activity — not because the tests would be expensive, but because nobody is required to run them. The chemicals entering the market today will be in bodies for years before the research catches up, if anyone funds the research at all.

Then there's the word 'fragrance.'

It's one word on a label. Behind it: roughly 4,000 possible ingredients. That number comes from the IFRAInternational Fragrance Association — the fragrance industry's self-regulatory body. Publishes the Transparency List of permitted fragrance ingredients. Transparency List, the fragrance industry's own catalog of compounds that can be formulated into a scent and sold without individual disclosure. EU and UK law treats fragrance formulations as trade secrets. Until recently, EU cosmetics regulation required just 26 named allergens — out of roughly 4,000 permitted fragrance ingredients to be disclosed by name above threshold — every other fragrance ingredient stayed hidden inside the word 'parfum.' A 2023 update (Regulation (EU) 2023/1545) has expanded the named list to around eighty substances, with transition deadlines rolling in across 2026 and 2028 — progress, and still a fraction of the catalog. A product labeled 'fragrance-free' may still contain masking agents designed to suppress the scent of other chemicals. A product labeled 'unscented' may still contain fragrance compounds used to neutralize smells — 'unscented' means the finished product doesn't smell like anything, not that it contains no fragrance chemicals.

The NRDCNatural Resources Defense Council — US environmental advocacy organization that conducts independent research and chemical testing. tested 14 common air fresheners in 2007 and found phthalates in 86% of air fresheners tested — including products labeled 'all-natural' and 'unscented.' The phthalates weren't disclosed on the label. They were inside the fragrance formulation, legally classified as a trade secret. 'Trade secret' is what the chemistry calls itself when it doesn't want to be read.

This pattern — a product marketed as the healthier option turning out to be measurably worse by a metric nobody thought to check — repeats more often than you'd expect.

Standard safety testing uses 3 dose points — the regulatory standard for each chemical. Detecting the actual biological effects of an endocrine disruptor takes an average of 6.9 dose points — more than double what the standard provides. That's the whole problem in two numbers — but to see why it matters, you need to know how the testing actually works.

A lab feeds the chemical to adult rats at three dose levels over 90 days to two years. They watch for visible harm: organ damage, tumor growth, weight change, behavioral abnormalities. They find the highest dose that produces none of it — the NOAELNo Observed Adverse Effect Level — the highest dose producing no detectable harm in animal studies. The foundation of every chemical 'safe dose' on a regulatory sheet., or no observed adverse effect level — and divide by a safety factor of 100. Ten because rats aren't humans. Ten more for variation between individual people. The result is the TDITolerable Daily Intake — the amount a person can theoretically consume every day for a lifetime without harm. Calculated by dividing the NOAEL by a safety factor of 100., or tolerable daily intake. That number becomes the regulatory standard. It goes on data sheets, into risk assessments, onto product approvals. And, as you'll see in a minute, it's sometimes wrong by a factor of twenty thousand.

One chemical. High dose. Adult animal. Oral route. Three dose points.

That model was designed in the mid-twentieth century for industrial chemicals and pesticides — substances that damage tissue directly, predictably, in proportion to dose. It was never built for chemicals that mimic hormones. The test animal is an adult, not a fetus in a critical developmental window. The route is oral, not twelve hours of dermal absorption from a moisturizer or inhalation from a bathroom full of aerosol spray. And it tests one chemical at a time. Nobody is exposed to one chemical at a time.

For conventional toxicants — cyanide, arsenic — this works. More dose means more harm, in a straight line. If a dose is safe, everything below it is safe too. The logic holds. But endocrine disruptors don't work like conventional poisons, because they don't kill cells. They talk to them. They mimic or block hormones, and your body uses hormones at extraordinarily low concentrations — parts per trillion — four drops in an Olympic swimming pool — to regulate development, reproduction, metabolism, and immunity.

At low doses, an EDCEndocrine Disrupting Chemical — the shorthand researchers use for this entire class of hormone-interfering compounds. slides into the same receptor locks your hormones use. It amplifies or blocks the signal. At high doses, the receptors saturate and shut down — they've seen too much. The result is a non-monotonic dose responseA dose-response relationship that doesn't follow a straight line. For endocrine disruptors, effects often peak at low doses and decline at high ones — the 'inverted U-curve' — opposite to what conventional toxicology assumes.: an inverted U-curve with maximum biological effect at low concentrations, declining effect at high ones. The opposite of what the testing model assumes.

Nearly one in four BPABisphenol A — a synthetic chemical used in polycarbonate plastics, can linings, and thermal receipts. The most thoroughly studied endocrine disruptor. experiments show this inverted-U pattern — 23.6% of BPA experiments in a systematic review of the dose-response literature Vandenberg 2014. Standard testing uses three dose points. Detecting an inverted U-curve requires an average of 6.9 dose points. Three points can't reveal a curve that peaks and falls — they'll draw a straight line through it and miss the bend entirely.

What this means in practice: a chemical declared safe at 50 micrograms per kilogram body weight might be maximally active at 0.5 — which happens to be the range of typical daily exposure from consumer products. The testing looked at high doses, found nothing, and concluded the chemical was safe all the way down. The most dangerous dose range was the one they never examined.

In 2023, EFSAEuropean Food Safety Authority — the EU agency responsible for assessing risks in the food chain, including chemical contaminants and additives. confronted this directly. They re-evaluated the full body of evidence on BPA — this time focusing on immune system effects, finding that even low concentrations shifted immune cell ratios toward allergic inflammation and autoimmune risk — and cut the tolerable daily intake from 4 micrograms per kilogram per day to 0.2 nanogramsA nanogram is one billionth of a gram — roughly the weight of a single human cell. Going from micrograms to nanograms means a thousand-fold reduction at the same dose number.. Not a modest reduction. Not a factor of two, or ten. A factor of 20,000×.

The previous limit had been the official standard for more than a decade. Millions of product approvals and safety assurances were built on it. After the revision, EFSA found that every age group — infants, children, adults — now exceeds the new safe dose through diet alone, by two to three orders of magnitude. The number that protected everyone for ten years was twenty thousand times too high. Everybody was already over it.

In 2002, researchers combined eight 'individually safe' chemicals and watched the mixture produce a strong estrogenic response that no single ingredient could explain on its own. That study predicted what happens every morning in your bathroom. Picture a Tuesday. You step into the shower, and chlorine in the water reacts with the organic matter on your skin to form trihalomethanesChemicals formed when chlorine disinfectant reacts with organic matter in water. Include chloroform and bromoform. Classified as probable human carcinogens. Absorbed through skin and inhaled from shower steam. — volatile compounds that absorb through your skin and lungs in the warm steam. You don't notice. You brush your teeth, and SLSSodium Lauryl Sulfate — a surfactant used as a foaming agent in roughly two-thirds of commercial toothpastes. in the toothpaste strips the protective mucinThe glycoprotein layer that coats and protects your oral epithelium. Acts as a physical and chemical barrier between soft tissue and whatever enters your mouth. layer from your gums — that's why your mouth stings slightly with certain brands. Triclosan was pulled from consumer antibacterial hand soap by the FDA in 2016 — manufacturers couldn't show it was safe or more effective than plain soap — but it remained permitted in toothpaste, because one company had submitted gingivitis data years earlier. You apply moisturizer — parabens and fragrance chemicals that will sit on your skin, absorbing through your dermis, for the next twelve to sixteen hours. You swipe on deodorant — aluminium compounds designed to block your sweat glands, applied to skin you may have just shaved, making it more permeable.

By the time you leave the bathroom, before breakfast, you've taken in dozens of chemicals through three simultaneous routes: ingestion, inhalation, and dermal absorption. Each one is within its individual regulatory limit. The specific combination your body is now processing has never been tested by anyone, because no regulatory framework on earth requires it.

One more variable changes the picture faster than you'd expect. In a 2014 experiment, participants used hand sanitizer — a routine gesture — then handled a thermal receipt, then ate French fries with their hands. The hand sanitizer stripped the skin's lipid barrier. The BPA coating on the receipt paper flooded through the compromised skin. Absorption jumped 185× compared to dry hands Hormann et al. 2014. Within minutes, blood serum BPA reached concentrations that animal studies had previously linked to adverse effects. The experiment wasn't contrived. It was an ordinary sequence: sanitize your hands, take your receipt, eat lunch. Each step unremarkable. The biology of the sequence was not.

The question of whether combinations of individually safe chemicals can produce measurable harm was answered definitively in 2002. Silva, Rajapakse, Kortenkamp, working at the University of London, selected eight xenoestrogensSynthetic chemicals that mimic estrogen in the body by binding to estrogen receptors — 'xeno' means foreign. Found in plastics, preservatives, UV filters, and pesticides. — estrogenic chemicals drawn from plastics, preservatives, UV filters, and PCBsPolychlorinated Biphenyls — a class of industrial chemicals banned in most countries since the late 1970s but still present in older electrical equipment, building materials, and the food chain. — and set each one below its individual no-effect concentration. Below the threshold where, tested alone, it produced any measurable response. Then they combined all eight.

The mixture produced a substantial estrogenic response. Eight nothings added up to something. The paper is titled Something From Nothing, and the title captures the entire argument in four words.

What makes the study remarkable, beyond the finding itself, is that the researchers predicted the result mathematically before running the experiment. They used a model called concentration additionA mathematical model that predicts mixture effects by summing each chemical's contribution proportional to its potency — assuming all chemicals act on the same biological target. Accurately predicts xenoestrogen cocktail effects. — a straightforward calculation that treats each chemical's contribution as additive, proportional to its potency — and the prediction matched. The cocktail effect isn't mysterious. It follows known mathematics. You can calculate what a combination will do if you know the individual components. As of 2026, no country on earth has adopted mixture-based safety testing as standard regulatory practice. The math exists. The policy doesn't.

Twenty-two years later, Braun et al. (2024) confirmed the same principle in actual human blood — not a simulated cocktail, but the real chemical mixture circulating in 624 pregnant women. The extract damaged developing nerve cells at concentrations where individual chemicals showed no effect.

Think about what that means. The chemicals in your blood right now — accumulated from food packaging, personal care products, household dust, drinking water, and thermal receipts — form a mixture that nobody designed, nobody approved, and nobody tested. It wasn't formulated. It wasn't reviewed by a safety board. It emerged from the sum of your daily exposures, and its biological effects are distinct from those of any individual chemical in it. The regulatory system evaluated each ingredient in isolation. Your body processes them simultaneously.

What's the cost of getting it wrong? The EU-wide health burden attributable to endocrine-disrupting chemical exposure runs to an estimated €157 billion/year 1.23% of EU GDP — 1.23% of GDP, comparable to the annual cost of diabetes Trasande et al. 2015. The single largest contributor: prenatal organophosphate pesticide exposure alone, costing Europe 13 million IQ points lost annually and €146 billion a year in lost lifetime productivity Bellanger et al. 2015.

Thirteen million IQ points. Annually. From chemicals the testing model declared safe.

And that estimate was calculated chemical by chemical. It doesn't include mixture effects, because no one has measured them at population scale. The true figure, accounting for how these chemicals interact inside the body, is higher. We just can't calculate how much higher yet.

Timing magnifies everything. Boys born to mothers in the highest quartile of prenatal monobutyl phthalatea phthalate metabolite used as a marker for exposure to dibutyl phthalate, found in personal care products and plastic packaging had 10.2× the odds of a shortened anogenital distanceThe distance between the anus and the genitals. In male infants, it's a developmental marker of how much testosterone signaling occurred in the womb — shorter distance indicates insufficient masculinization during fetal development. compared to the lowest quartile — ordinary consumer exposure levels, not occupational Swan et al. 2005. The same phthalate at the same dose in an adult produces no measurable effect. A fetus isn't a small adult. Its hormone receptors aren't maintaining a stable system — they're building one from scratch. A hormonal signal that barely registers in a grown body can redirect developmental architecture entirely.

The critical windows aren't limited to fetal development. Puberty, pregnancy, and menopause are all periods when the endocrine system is actively reconfiguring, not just maintaining. Exposure during these transitions operates by different biological rules, and the standard testing model doesn't distinguish between them.

Almost every plastic product tested — including those marketed as 'BPA-free' — releases chemicals with measurable estrogenic activity Yang et al. 2011. That's what happens when a chemical gets banned. A chemical accumulates enough evidence of harm — decades of studies, public pressure, maybe a lawsuit — and regulators restrict it. The ban removes the chemical consumers recognize. What happens next is predictable: the manufacturer replaces it with a structural analogue that does the same job but hasn't been through equivalent scrutiny. The replacement isn't tested for the same biological endpoints. There's no legal requirement to do so.

The regulatory framework evaluates chemicals individually, not by class. A ban on BPA doesn't trigger review of structurally similar bisphenols. A restriction on one PFAS compound doesn't require testing of the thousands of others in the class. The manufacturer's legal obligation ends at removing the named chemical. So they remove it, add a close cousin, and put 'free-from' on the label. The consumer sees progress. The molecule sees a name change.

BPA — bisphenol A (C₁₅H₁₆O₂) — is the most thoroughly documented case. It was banned from baby bottles across the EU after evidence of estrogenic activity (Banned in EU baby bottles). Industry replaced it with BPS, BPF, and BPAF, all structurally similar bisphenols. Rochester and Bolden 2015 systematically reviewed 32 studies of these substitutes and found BPS and BPF are about as hormonally active as BPA itself — equally estrogenic, antiestrogenic, androgenic, and antiandrogenic in the assays tested, with BPS binding estradiol's membrane receptors at comparable potencies.

A 2024 in-vitro screen went further, running all eleven common BPA analogues through a test battery at Goethe University Frankfurt. Most showed estrogenic and anti-androgenic activity equal to or greater than BPA — the replacements could not be regarded as safer alternatives, which is the definition of a regrettable substitution Reininger and Oehlmann 2024. Separately, Yang et al. 2011 tested plastic products directly and found that almost all commercially available plastics — including those marketed as 'BPA-free' — released chemicals with measurable estrogenic activity. The 'BPA-free' label means they removed the one bisphenol consumers have heard of. What replaced it is usually estrogenically active too.

The same pattern repeats across chemical classes. PFOA was restricted under the Stockholm Convention; its GenX replacement produced neonatal mortality and hepatomegalyabnormal enlargement of the liver — a sign of systemic toxicity in rat reproductive studies Conley et al. 2021. Penta-BDE flame retardants were phased out for neurodevelopmental and endocrine concerns; their organophosphatea class of synthetic phosphorus-based flame retardants and pesticides replacements disrupted placenta formation in lab-grown human placental tissue Xu et al. 2022. Paper straws replaced plastic for environmental reasons, but Boisacq et al. 2023 tested 39 brands across five materials and found PFAS in almost every paper and bamboo straw they tested — the fluorinated coating that makes plant fibre resist liquid is exactly the class of forever chemicals the environmental swap was supposed to avoid.

PFAS is worth understanding in detail, because the structural forces that delayed it apply to every other under-regulated chemical.

3M and DuPont ran internal toxicity studies on PFAS in the 1950s and 1960s. They kept the results confidential. By the time EFSAEuropean Food Safety Authority cut the tolerable weekly intake for four of the most-studied PFAS by more than a thousand-fold in 2020, and the EU proposed a universal restriction on all ~10,000 compounds in the class in 2023, roughly six decades had passed. The UK is still consulting on binding drinking-water limits for England and Wales as of 2026 (England/Wales: still in consultation).

And PFAS had every possible accelerant. A class-action lawsuit that became a Hollywood film. Years of investigative journalism. Contamination so widespread that national water-testing programs have found it in source and tap water across multiple countries. If any chemical was going to move through the regulatory system quickly, it was PFAS. It still took sixty years.

The structural barriers aren't unique to PFAS. The burden of proof sits on regulators, not manufacturers — a company can sell a product until a government body proves it's harmful, and proving harm requires years of funded research, peer review, political consensus, and legal battles against well-resourced industry. The system evaluates chemicals one at a time, even though nobody is exposed to one at a time. It tests on adult animals, even though the most vulnerable populations are fetuses and children. And when it does act, the typical response is to restrict that specific compound — not to evaluate the class — which is how BPA gets banned and BPS fills the gap without review.

The regulatory process that took 60 years for PFAS, revised BPA's safe dose by a factor of 20,000× after more than ten years of getting it wrong, and still hasn't adopted mixture testing 24 years after the science proved it was necessary — that process is not designed to keep pace with the chemicals in your bathroom cabinet. The research exists. The ingredient lists are on the bottles. Connecting those two things is something you can do faster than the system.

You need three questions. Not a chemistry degree — three questions, the same three a toxicologist would ask, applied to any product you can pick up off a shelf. Most of what's on your shelf is probably fine. The label won't tell you which bits aren't, but the research will.

Mechanism. Could this chemical plausibly interact with your biology in a way that causes harm? Does it bind to hormone receptors? Accumulate in tissue instead of clearing? Cross the placenta? If the answer to any of these is yes, the chemical has a plausible mechanism for harm — regardless of what the current regulatory status says.

Evidence. Do peer-reviewed studies find effects consistent with that mechanism? Animal studies, human epidemiology, in vitro assays, biomonitoring data — any of these count. You're not looking for proof of harm. You're looking for consistency between what the mechanism predicts and what the research finds.

Context. Does the real-world exposure scenario match what the studies measured? A chemical in a cleaning spray you use for thirty seconds and rinse off is a different proposition from the same chemical in a moisturizer that sits on your skin for sixteen hours. Are you pregnant? That changes which doses matter. Is this chemical one of dozens in a product, combined with hundreds more across your daily routine? That changes everything.

Here's what that looks like applied to a real product. Pick up your moisturizer and flip it over. You see 'methylparaben' on the ingredient list. Mechanism: parabens bind to estrogen receptors — the same molecular locks your natural hormones use to signal cells. That's a plausible route to endocrine disruption. Evidence: multiple in vitro studies demonstrate estrogenic activity; intact parabens have been detected in human breast tissue Darbre et al. 2004, which means the body doesn't fully metabolize them on contact — they persist. Context: this moisturizer sits on your skin for twelve to sixteen hours, absorbing continuously through the dermis. You apply it daily, so the exposure is chronic. Three checks, all pointing the same direction. You don't need to prove methylparaben is harmful. You need to notice that the mechanism is plausible, the evidence is consistent, and paraben-free moisturizers cost the same. That's enough to try one.

Where the science isn't settled — fluoride, EMF, aluminium — the same three questions still apply. If the mechanism is plausible, studies find consistent effects, and an alternative exists that avoids the question entirely, we'd use the alternative. Waiting for scientific consensus is reasonable in an academic context. When you're choosing between two products that cost the same, one of which raises a question and the other doesn't, it's reasonable to just avoid the question.

Think back to the bottle in the shower. The one you picked up, flipped over, and couldn't read. The ingredients were already there. The research was already on PubMed. The gap between those two things — what's in the product and what the studies say about it — was a search bar and fifteen minutes of reading.

Once you start closing that gap, it's hard to stop. You look up methylisothiazolinone, learn it was restricted in EU leave-on products back in 2016 but is still allowed in rinse-off, and wonder why you didn't check sooner. You see 'fragrance' on four different bottles and remember it could mean any of thousands of things. You see 'BPA-free' on a water bottle and remember that it says nothing about what replaced the BPA. You pick it up anyway, because you can't remember what BPS is. You look it up. It's estrogenically comparable.

That's not panic. It's just the kind of thinking you'd apply to anything else that goes into your body every day for decades. The regulatory system will catch up eventually. It always does. It just takes sixty years — and in the meantime, the ingredient list is right there on the back of the bottle. The back, not the front. Where it's always been.